Table 2.
CHKA gene | Cases (%) | Controls (%) | OR (95% CI) | aOR (95% CI) |
SNP hCV1562388 (A>C) | ||||
AA | 54 (54.0) | 138 (41.2) | Reference | - |
AC | 38 (38.0) | 154 (46.0) | 0.63 (0.39–1.01) | 0.62 (0.39–1.00) |
CC | 8 (8.0) | 43 (12.8) | 0.48 (0.21–1.08) | 0.48 (0.21–1.10) |
AC+CC | 46 (46.0) | 197 (58.8) | 0.60 (0.38–0.94) | 0.55(0.38–0.99) |
SNP hCV1562393(C>G) | ||||
CC | 66 (67.3) | 225 (67.6) | Reference | - |
CG+GG | 32 (32.6) | 108 (32.4) | 0.99 (0.61–1.62) | 1.01 (0.62–1.66) |
PCYT1A gene | Cases (%) | Controls (%) | OR (95% CI) | aOR (95% CI) |
SNP rs939883 (T>A) | ||||
TT | 35 (34.3) | 132 (39.9) | Reference | - |
TA | 48 (47.1) | 161 (48.6) | 1.12 (0.69–1.84) | 1.14 (0.70–1.87) |
AA | 19 (18.6) | 38 (11.5) | 1.89(0.97–3.67) | 1.85 (0.95–3.61) |
SNP rs3772109 (T>C) | ||||
TT | 33 (33.7) | 104 (31.2) | Reference | - |
TC | 51 (52.0) | 164 (49.2) | 0.98 (0.59–1.62) | 0.99 (0.60–1.65) |
CC | 14 (14.3) | 65 (19.5) | 0.68 (0.34–1.36) | 0.69 (0.34–1.41) |